The original viibryd dose level can be resumed when the cyp3a4 inhibitor is discontinued see drug interactions.
Viibryd dosage range.
To achieve the target dosage titrate viibryd as follows.
The original viibryd dose level can be resumed when the cyp3a4 inhibitor is discontinued see drug interactions.
If patient is taking 20 mg day taper dose to 10 mg qday for 7 days.
Take viibryd with food.
Viibryd starting dose is typically 10 mg orally once a day for 7 days followed by 20 mg orally once a day for an additional 7 days maintenance dose is 20 40 mg orally once a day.
Patients receiving concomitant cyp3a4 inducers.
2 1 dosage for treatment of major depressive disorder the recommended target dosage for viibryd is 20 mg to 40 mg orally once daily with food see clinical pharmacology 12 3 clinical studies 14.
Patients receiving concomitant cyp3a4 inducers based on clinical response consider increasing the dosage of viibryd by 2 fold up to a maximum 80 mg once daily over 1 to 2 weeks in patients taking strong cyp3a4 inducers e g.
The maximum recommended dose is 80 mg per day.
The viibryd dose should not exceed 20 mg once daily if co administered with strong cyp3a4 inhibitors eg itraconazole clarithromycin voriconazole.
At the end of the clinical study most of the patients 67 received 20 mg or 40 mg once daily see clinical studies.
Start with an initial dosage of 10 mg once daily with food for 7 days.
A drug called viibryd vilazodone promises to provide relief with fewer adverse effects and clinical studies suggest that it s significantly less likely to cause weight gain and sexual dysfunction two side effects that often lead people to go off of other antidepressants.
Based on clinical response consider increasing the dosage of viibryd by 2 fold up to a maximum 80 mg once daily over 1 to 2 weeks in patients taking strong cyp3a4 inducers e g.
Viibryd comes in 10 mg 20 mg and 40 mg tablets.
After that your dose will be increased to 20 mg once daily for 7 days.
The original viibryd dose level can be resumed when the cyp3a4 inhibitor is discontinued.
Based on clinical response consider increasing the dosage of viibryd by 2 fold up to a maximum 80 mg once daily over 1 to 2 weeks in patients taking strong cyp3a4 inducers e g.
The dose may be increased after one week based on clinical response.
Most likely your doctor will start you with a 10 mg dose once daily for 7 days.
Follow by reducing dose to 10 mg qday for 3 days.
Patients receiving concomitant cyp3a4 inducers.
In patients taking 40 mg day taper dose to 20 mg qday for 4 ddays.
